OSCR

Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology.

Overview

Authors: Xiaoyun Hu1, Yuning Zeng2, Junjie Li3, Qiongxi Lin4, Zixuan Liang2, Jing Zhang5, Meirong Jiang1, Shuoshuo Gao1, Hua Liu1
  1. Department of Pediatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
  2. The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
  3. College of Computer Science, Guangdong Polytechnic Normal University, Guangzhou, Guangdong, China
  4. Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China
  5. Department of Emergency, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
Journal: Frontiers in microbiology, volume 17, article 1811435
Dates: received 14 February 2026; accepted 14 July 2026; published online 4 August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fmicb.2026.1811435 · PMID 42614415 · PMCID PMC13481684 · OpenAlex W7172453636
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), mouse (organism), autism (population), systems (subfield)
Methods: Spectral & time-frequency, Statistics, Smoothing, state filtering, decompositions, Machine learning, Connectivity, fMRI & imaging
Keywords: 16S rRNA sequencing, autism spectrum disorder, gut-brain communication, metabolomics, network pharmacology
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 71 references in the paper

Abstract

Objective: The relationship and underlying mechanisms linking the gut microbiota, metabolites and autism spectrum disorder (ASD) have not been fully elucidated.

Methods: In the present study, network pharmacology was combined with machine learning for a systematic investigation into the possible action mechanisms between metabolites derived from the gut microbiota and their targets in ASD. Subsequently, untargeted metabolomics analysis and 16S rRNA sequencing were utilized for investigating alterations in differential metabolites and the composition of principal gut microbiota between normal and BTBR mice.

Results: The findings demonstrated that five characteristic targets: CXCR3, HCAR2, HTR1A, IL-6 and NFKB1 modulated by the gut microbiota and gut microbiota’s metabolites were significantly associated with ASD. The M-S-M-T network prioritized 21 candidate gut-microbiota-derived metabolites, including phenylacetic acid and coumarin. These candidates were generated from database-based target prediction and should be interpreted separately from the differential metabolites detected in fecal metabolomics. Metabolomic and 16S rRNA sequencing analyses revealed that BTBR mice displayed metabolic dysregulation and disrupted gut microbiota composition compared with normal ones. These findings suggest that phenylalanine metabolism and neuroactive ligand-receptor interaction may be associated with ASD-like behavioral phenotypes in BTBR mice and warrant further experimental validation. The gut microbiota-metabolite-behavior network analysis further uncovered significant associations among the behavioral characteristics of ASD, alterations in gut microbiota composition and markedly altered metabolite profiles.

Conclusion: By integrating network pharmacology, transcriptomic re-analysis, fecal metabolomics and 16S rRNA sequencing, this study identifies candidate microbe-metabolite-target associations related to ASD-like phenotypes. These results provide testable hypotheses for future mechanistic studies of gut-brain communication in ASD.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data availability statement

The original contributions presented in the study are publicly available. The main data generated or analyzed during this study are included in this manuscript and its additional files and are available from the corresponding author on reasonable request. 16s rRNA sequencing data can be found at: https://www.ncbi.nlm.nih.gov/sra/PRJNA1496513.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 9 authors, 5 keywords, 71 references.

Cite

This paper

Hu, X., Zeng, Y., Li, J., Lin, Q., Liang, Z., Zhang, J., Jiang, M., Gao, S., & Liu, H. (2026). Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology. Frontiers in microbiology, 17, 1811435. https://doi.org/10.3389/fmicb.2026.1811435

BibTeX

@article{hu2026research,
author = {Hu, Xiaoyun and Zeng, Yuning and Li, Junjie and Lin, Qiongxi and Liang, Zixuan and Zhang, Jing and Jiang, Meirong and Gao, Shuoshuo and Liu, Hua},
title = {{Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology}},
journal = {Frontiers in microbiology},
year = {2026},
month = aug,
volume = {17},
pages = {1811435},
publisher = {Frontiers Media SA},
issn = {1664-302X},
doi = {10.3389/fmicb.2026.1811435},
url = {https://doi.org/10.3389/fmicb.2026.1811435},
pmid = {42614415},
pmcid = {PMC13481684}
}

RIS

TY - JOUR
AU - Hu, Xiaoyun
AU - Zeng, Yuning
AU - Li, Junjie
AU - Lin, Qiongxi
AU - Liang, Zixuan
AU - Zhang, Jing
AU - Jiang, Meirong
AU - Gao, Shuoshuo
AU - Liu, Hua
TI - Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology
T2 - Frontiers in microbiology
J2 - Front Microbiol
PY - 2026
DA - 2026/08/04
VL - 17
SP - 1811435
SN - 1664-302X
PB - Frontiers Media SA
DO - 10.3389/fmicb.2026.1811435
UR - https://doi.org/10.3389/fmicb.2026.1811435
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fmicb.2026.1811435",
"type": "article-journal",
"title": "Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology",
"container-title": "Frontiers in microbiology",
"author": [
{
"family": "Hu",
"given": "Xiaoyun"
},
{
"family": "Zeng",
"given": "Yuning"
},
{
"family": "Li",
"given": "Junjie"
},
{
"family": "Lin",
"given": "Qiongxi"
},
{
"family": "Liang",
"given": "Zixuan"
},
{
"family": "Zhang",
"given": "Jing"
},
{
"family": "Jiang",
"given": "Meirong"
},
{
"family": "Gao",
"given": "Shuoshuo"
},
{
"family": "Liu",
"given": "Hua"
}
],
"container-title-short": "Front Microbiol",
"volume": "17",
"page": "1811435",
"DOI": "10.3389/fmicb.2026.1811435",
"PMID": "42614415",
"PMCID": "PMC13481684",
"ISSN": "1664-302X",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fmicb.2026.1811435",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
4
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12888-026-08178-8 [code]
Machine learning model to identify gut microbiome-derived metabolites as potential biomarkers of autism spectrum disorder: a pilot study.
Journal: BMC psychiatry
In common: autism, genetics / omics, 4 references
[2] doi:10.1038/s41467-025-61544-0 [code]
Gut microbiota and brain-resident CD4<sup>+</sup> T cells shape behavioral outcomes in autism spectrum disorder.
Journal: Nature communications
In common: autism, mouse, 4 references
[3] doi:10.3389/fmicb.2024.1331130
Microbiota profiling reveals alteration of gut microbial neurotransmitters in a mouse model of autism-associated 16p11.2 microduplication.
Journal: Frontiers in microbiology
In common: autism, genetics / omics, mouse, 3 references
[4] doi:10.3389/fmicb.2026.1885281
Washed microbiota transplantation improves clinical symptoms, gut microbiota, and metabolic profiles in autism spectrum disorder in a twin cohort.
Journal: Frontiers in microbiology
In common: autism, genetics / omics, 3 references
[5] doi:10.1038/s41598-025-91344-x
Exploring the active ingredients and potential mechanisms of Pingchan granules in Parkinson's disease treatment through network pharmacology and transcriptomics.
Journal: Scientific reports
In common: genetics / omics, 5 references
[6] doi:10.1080/19490976.2024.2385524 [code]
Supplier-origin gut microbiomes affect host body weight and select autism-related behaviors.
Journal: Gut microbes
In common: autism, mouse, 3 references
[7] doi:10.1128/msystems.00608-22
Unique Features of the Gut Microbiome Characterized in Animal Models of Angelman Syndrome.
Journal: mSystems
In common: genetics / omics, mouse, 3 references
[8] doi:10.1021/acsomega.4c00200
Investigating the Mechanistic of Danhong Injection in Brain Damage Caused by Cardiac I/R Injury via Bioinformatics, Computer Simulation, and Experimental Validation.
Journal: ACS omega
In common: 4 references
[9] doi:10.3390/cimb48040369
Elucidating the Multi-Target Anti-Pruritic Mechanism of <i>Polygonatum odoratum</i> via Integrated Network Pharmacology, Molecular Simulations, and GEO Dataset Validation.
Journal: Current issues in molecular biology
In common: 4 references
[10] doi:10.3390/nu15071620
Intestinal Barrier Dysfunction and Microbiota-Gut-Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.
Journal: Nutrients
In common: autism, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.